These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15589014)

  • 1. Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries.
    Hoffmann R; Radke PW; Ortlepp JR; Haager PK; Blindt R; Iofina E; Franke A; Langenberg R; Weber C; Hanrath P
    Am J Cardiol; 2004 Dec; 94(12):1548-50. PubMed ID: 15589014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study.
    Hoffmann R; Jansen C; König A; Haager PK; Kerckhoff G; vom Dahl J; Klauss V; Hanrath P; Mudra H
    Eur Heart J; 2001 Nov; 22(21):2007-14. PubMed ID: 11603908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
    Serruys PW; Sianos G; Abizaid A; Aoki J; den Heijer P; Bonnier H; Smits P; McClean D; Verheye S; Belardi J; Condado J; Pieper M; Gambone L; Bressers M; Symons J; Sousa E; Litvack F
    J Am Coll Cardiol; 2005 Jul; 46(2):253-60. PubMed ID: 16022951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of intimal hyperplasia after sirolimus-eluting stent and thin-strut bare-metal stent implantation in small coronary arteries].
    Devito FS; Sousa AG; Feres F; Abizaid AA; Staico R; Mattos LA; Tanajura LF; Abizaid AC; Chaves AJ; Sousa JE
    Arq Bras Cardiol; 2006 Apr; 86(4):268-75. PubMed ID: 16680291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
    Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ
    J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
    Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
    J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus.
    Kimura M; Mintz GS; Weissman NJ; Dawkins KD; Grube E; Ellis SG; Cannon LA; Masud Z; Mandinov L; Baim D; Stone GW
    Am J Cardiol; 2008 May; 101(9):1263-8. PubMed ID: 18435955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries.
    Jabara R; Chronos N; Tondato F; Conway D; Molema W; Park K; Mabin T; King S; Robinson K
    J Invasive Cardiol; 2006 Aug; 18(8):383-90. PubMed ID: 16877788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
    Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
    N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
    Liuzzo JP; Ambrose JA; Coppola JT
    J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of intimal hyperplasia thickness to stent size in paclitaxel-coated stents.
    Escolar E; Mintz GS; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2004 Jul; 94(2):196-8. PubMed ID: 15246900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
    Mintz GS; Tinana A; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Circulation; 2003 Sep; 108(11):1295-8. PubMed ID: 12952833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.